Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Matthay

Showing results (231-240 of 316) with videos related to

Pageof 32
Sort By:
Radiation Research|October 21, 2021
Peripheral Blood Transcript Signatures after Internal 131I-mIBG Therapy in Relapsed and Refractory Neuroblastoma Patients Identifies Early and Late Biomarkers of Internal 131I ExposuresAngela C Evans, Tim Setzkorn, David A Edmondson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium StudyKatherine K Matthay, Jessica C Tan, Judith G Villablanca, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|January 19, 2018
Estimation of intra-arterial chemotherapy distribution to the retina in pediatric retinoblastoma patients using quantitative digital subtraction angiographySravani Kondapavulur, Daniel L Cooke, Andrew Kao, et al.
Medical and Pediatric Oncology|July 24, 2001
Comprehensive analysis of chromosome 1p deletions in neuroblastomaJ M Maris, C Guo, D Blake, et al.
Pediatric Blood & Cancer|July 22, 2014
Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group projectHolly J Meany, Wendy B London, Peter F Ambros, et al.
Hormone Research|December 5, 1998
Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related proteinK Loh, K K Matthay, M Hoover, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2016
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group databaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG)Paul A Fitzgerald, Robert E Goldsby, John P Huberty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group projectKieuhoa T Vo, Katherine K Matthay, John Neuhaus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group studyK K Matthay, C Perez, R C Seeger, et al.
Pageof 32

Showing results (231-240 of 316) with videos related to

Sort By:
Pageof 32
Radiation Research|October 21, 2021
Peripheral Blood Transcript Signatures after Internal 131I-mIBG Therapy in Relapsed and Refractory Neuroblastoma Patients Identifies Early and Late Biomarkers of Internal 131I ExposuresAngela C Evans, Tim Setzkorn, David A Edmondson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium StudyKatherine K Matthay, Jessica C Tan, Judith G Villablanca, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|January 19, 2018
Estimation of intra-arterial chemotherapy distribution to the retina in pediatric retinoblastoma patients using quantitative digital subtraction angiographySravani Kondapavulur, Daniel L Cooke, Andrew Kao, et al.
Medical and Pediatric Oncology|July 24, 2001
Comprehensive analysis of chromosome 1p deletions in neuroblastomaJ M Maris, C Guo, D Blake, et al.
Pediatric Blood & Cancer|July 22, 2014
Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group projectHolly J Meany, Wendy B London, Peter F Ambros, et al.
Hormone Research|December 5, 1998
Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related proteinK Loh, K K Matthay, M Hoover, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2016
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group databaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG)Paul A Fitzgerald, Robert E Goldsby, John P Huberty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group projectKieuhoa T Vo, Katherine K Matthay, John Neuhaus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group studyK K Matthay, C Perez, R C Seeger, et al.
Pageof 32